Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target.
Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target.
复制标题
主动脉瘤与主动脉夹层中的细胞程序性死亡:一个潜在的治疗靶点
DOI:
10.1016/j.yjmcc.2021.09.010
复制
发表时间:
2022-03
影响因子:
5
通讯作者:
Shen YH
中科院分区:
文献类型:
--
作者:
Chakraborty A;Li Y;Zhang C;Li Y;LeMaire SA;Shen YH
Rupture of aortic aneurysm and dissection (AAD) remains a leading cause of death. Progressive smooth muscle cell (SMC) loss is a crucial feature of AAD that contributes to aortic dysfunction and degeneration, leading to aortic aneurysm, dissection, and, ultimately, rupture. Understanding the molecular mechanisms of SMC loss and identifying pathways that promote SMC death in AAD are critical for developing an effective pharmacologic therapy to prevent aortic destruction and disease progression. Cell death is controlled by programmed cell death pathways, including apoptosis, necroptosis, pyroptosis, and ferroptosis. Although these pathways share common stimuli and triggers, each type of programmed cell death has unique features and activation pathways. A growing body of evidence supports a critical role for programmed cell death in the pathogenesis of AAD, and inhibitors of various types of programmed cell death represent a promising therapeutic strategy. This review discusses the different types of programmed cell death pathways and their features, induction, contributions to AAD development, and therapeutic potential. We also highlight the clinical significance of programmed cell death for further studies.
登录
查看更多内容
影响因子:
37.8
作者:
Bonderman, D;Gharehbaghi-Schnell, E;Lang, IM
通讯作者:
Lang, IM
影响因子:
7.5
作者:
Cai J;Zhang M;Liu Y;Li H;Shang L;Xu T;Chen Z;Wang F;Qiao T;Li K
通讯作者:
Li K
影响因子:
--
作者:
Ayala A;Muñoz MF;Argüelles S
通讯作者:
Argüelles S
影响因子:
2.5
作者:
Chen Y;Xiong N;Wang X;Wu S;Hong L;Huang X;Chen C;Li W;Wang B;Ye S;Tan X
通讯作者:
Tan X
影响因子:
1.5
作者:
Bai, Yang;Zhang, Qiangnu;Li, Kunsheng
通讯作者:
Li, Kunsheng